UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C902. A total of 3 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $632 | -20.4% | 2,800 | -22.2% | 0.00% | -100.0% |
Q2 2023 | $794 | +10.9% | 3,600 | +12.5% | 0.00% | 0.0% |
Q1 2023 | $716 | -75.0% | 3,200 | -68.9% | 0.00% | -66.7% |
Q4 2022 | $2,864 | -99.9% | 10,300 | -34.0% | 0.00% | -25.0% |
Q3 2022 | $3,266,000 | +296.4% | 15,600 | +345.7% | 0.00% | +300.0% |
Q2 2022 | $824,000 | -68.3% | 3,500 | -75.9% | 0.00% | -50.0% |
Q1 2022 | $2,601,000 | -18.1% | 14,500 | -1.4% | 0.00% | -33.3% |
Q4 2021 | $3,176,000 | -31.2% | 14,700 | -41.2% | 0.00% | -25.0% |
Q3 2021 | $4,616,000 | +3.3% | 25,000 | +0.4% | 0.00% | 0.0% |
Q2 2021 | $4,467,000 | – | 24,900 | +6684.7% | 0.00% | – |
Q1 2021 | $0 | -100.0% | 367 | +144.7% | 0.00% | -100.0% |
Q4 2020 | $2,276,000 | +118.8% | 150 | +45.6% | 0.00% | +200.0% |
Q3 2020 | $1,040,000 | +56.4% | 103 | +87.3% | 0.00% | 0.0% |
Q2 2020 | $665,000 | +40.3% | 55 | +10.0% | 0.00% | 0.0% |
Q1 2020 | $474,000 | -47.2% | 50 | -51.0% | 0.00% | -50.0% |
Q4 2019 | $898,000 | +78.9% | 102 | +61.9% | 0.00% | +100.0% |
Q3 2019 | $502,000 | +304.8% | 63 | +293.8% | 0.00% | – |
Q2 2019 | $124,000 | -92.6% | 16 | -88.7% | 0.00% | -100.0% |
Q1 2019 | $1,666,000 | +7833.3% | 142 | +7000.0% | 0.01% | – |
Q4 2018 | $21,000 | -99.0% | 2 | -98.8% | 0.00% | -100.0% |
Q3 2018 | $2,173,000 | -27.3% | 170 | -35.6% | 0.01% | -41.7% |
Q2 2018 | $2,987,000 | +12887.0% | 264 | +103.1% | 0.01% | +1100.0% |
Q1 2018 | $23,000 | -52.1% | 130 | +209.5% | 0.00% | -50.0% |
Q4 2017 | $48,000 | +2300.0% | 42 | +250.0% | 0.00% | – |
Q3 2017 | $2,000 | -96.7% | 12 | 0.0% | 0.00% | -100.0% |
Q2 2017 | $61,000 | -44.5% | 12 | -83.3% | 0.00% | -40.0% |
Q1 2017 | $110,000 | -4.3% | 72 | -30.8% | 0.01% | -28.6% |
Q4 2016 | $115,000 | +210.8% | 104 | -35.4% | 0.01% | +133.3% |
Q3 2016 | $37,000 | +60.9% | 161 | -14.8% | 0.00% | +50.0% |
Q2 2016 | $23,000 | +64.3% | 189 | +57.5% | 0.00% | +100.0% |
Q1 2016 | $14,000 | -46.2% | 120 | +344.4% | 0.00% | -50.0% |
Q4 2015 | $26,000 | +550.0% | 27 | -37.2% | 0.00% | – |
Q3 2015 | $4,000 | -90.2% | 43 | -48.2% | 0.00% | -100.0% |
Q2 2015 | $41,000 | +13.9% | 83 | +76.6% | 0.00% | -25.0% |
Q1 2015 | $36,000 | -12.2% | 47 | -56.9% | 0.00% | -20.0% |
Q4 2014 | $41,000 | – | 109 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Garda Capital Partners LP | 4,000 | $903,480 | 0.04% |
JANE STREET GROUP, LLC | 14,500 | $3,275,115 | 0.00% |
SIMPLEX TRADING, LLC | 2,800 | $632 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |